Biotechnology Industry in India

What Biotechnology Industry in India does

Merck KGaA, Darmstadt, Germany is a diversified global science and technology company organized into three business sectors: Life Science, Healthcare, and Electronics. The Life Science sector supplies tools, reagents, and process solutions to research institutions, pharmaceutical companies, biotech firms, and diagnostics laboratories via its Process Solutions, Advanced Solutions, and Discovery Solutions units (branded MilliporeSigma in the US and Canada). The Healthcare sector delivers pharmaceutical therapies across oncology, neurology and immunology, fertility, cardiovascular/metabolism/endocrinology, and rare tumors through EMD Serono in the US/Canada, alongside a stated patient-centered commercial approach. The Electronics sector supplies semiconductor and display manufacturers with thin films, optronics, formulations, metrology and inspection, delivery systems and services, specialty gases, and the Intermolecular® custom innovation platform, sold as EMD Electronics in the US/Canada.

The company operates across 65 countries with 62,000+ employees and reports proprietary technology in mRNA, life-science reagents, pharmaceutical compounds, and electronics materials. Recent disclosure flags an emerging-biotech support franchise offering guidance, grants, collaboration centers, and end-to-end manufacturing solutions. Revenue mechanics are B2B enterprise: quote-based, primarily annual subscriptions for Life Science tools, project/one-time licensing for Healthcare products, and hardware/material sales for Electronics, all routed through direct enterprise sales teams and regional subsidiaries.

Commercial activity in late 2025 and 2026 includes a US$11.3 billion (EUR 9.9 billion) agreed acquisition of Bio-Techne to deepen Life Science leadership and the launch of a state-of-the-art high-performance computing system in Munich, built with Lenovo and Equinix to support research, data analytics, and AI workloads. The company's primary first-party sources describe it as publicly traded (ticker MRK) with active capital-markets engagement, headquartered at Frankfurter Strasse 250, Darmstadt, Germany.

Name

Biotechnology Industry in India

Legal name

Merck KGaA, Darmstadt, Germany

Website

https://merckgroup.com

Company type

Public

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Merck KGaA, Darmstadt, Germany is a diversified science and technology company operating Life Science, Healthcare, and Electronics businesses, serving research institutions, pharmaceutical and biotech firms, healthcare providers, and semiconductor manufacturers worldwide.

Ownership category

akta.pro rank

Product category

Life Sciences and Pharmaceutical Technology

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Biological Product (except Diagnostic) Manufacturing (325414), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Computer and Electronic Product Manufacturing (334), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Miscellaneous Chemical Products (2890), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI)

akta.pro secondary industries

mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL), Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ), Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES) (HLAAAJAE)

Keywords

• Life science tools
• Biopharmaceutical solutions
• Pharmaceutical therapeutics
• Semiconductor materials
• Research reagents

Headquarters

HQ city

Darmstadt

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Life Science: Products and services for life science research and biopharmaceutical production including tools, reagents, and process solutions for drug research, biotechnology, and diagnostics.
2. Healthcare: Pharmaceutical products and therapies for oncology, neurology, immunology, fertility, and cardiovascular diseases serving healthcare providers and patients.
3. Electronics: Materials, chemicals, and equipment for semiconductor manufacturing, display technologies, and electronics industries.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Merck KGaA, Darmstadt, Germany supplies life science tools, reagents, and biopharmaceutical process solutions; healthcare therapies in oncology, neurology, immunology, fertility, and cardiovascular disease; and electronics materials and equipment (thin films, optronics, formulations, metrology, specialty gases) for semiconductor and display manufacturers. In India, the company supports emerging biotech with guidance, grants, collaboration centers, and end-to-end manufacturing solutions.

Product overview

Merck KGaA, Darmstadt, Germany is a vibrant science and technology company organized into three business sectors: Life Science, Healthcare, and Electronics. The Life Science sector encompasses Process Solutions, Advanced Solutions, and Discovery Solutions providing tools for biopharmaceutical production and research. The Healthcare sector focuses on therapeutic areas including Oncology, Neurology & Immunology, Fertility, Cardiovascular/Metabolism/Endocrinology, and Rare Tumors. The Electronics sector provides technology platforms including Thin Films, Optronics, Formulations, Metrology and Inspection, Delivery Systems & Services, Specialty Gases, and the Intermolecular® custom innovation brand for semiconductor manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

• Process Solutions: Life Science business unit providing process solutions
• Advanced Solutions
• Discovery Solutions

Products and services

• Process Solutions Life Science business unit providing process solutions for biopharmaceutical production, industrial microbiology, and manufacturing workflows. Used by pharmaceutical companies and biotech firms for production-scale operations.
• Advanced Solutions Life Science business unit offering advanced tools and technologies for research and development applications. Targets researchers performing experiments and engineering new products.
• Discovery Solutions Life Science business unit focused on discovery research tools, reagents, and screening technologies. Serves scientists engaged in drug discovery and early-stage research.
• Oncology Therapeutics Healthcare therapeutic area providing cancer treatment solutions including targeted therapies and immunotherapies. For oncology specialists and healthcare providers treating cancer patients.
• Neurology and Immunology Therapeutics Healthcare therapeutic area addressing neurological disorders and immune system diseases. Distributed under the EMD Serono brand to healthcare providers.
• Fertility Therapeutics Healthcare therapeutic area providing treatments and solutions for reproductive health and fertility. Serves fertility specialists and patients seeking reproductive care.
• Cardiovascular, Metabolism and Endocrinology Therapeutics Healthcare therapeutic area covering heart diseases, metabolic disorders, and hormonal conditions. Prescribed by cardiologists, endocrinologists, and general medicine practitioners.
• Rare Tumors Therapeutics Healthcare therapeutic area focused on treatments for rare and uncommon cancer types. Targeted at oncology specialists managing rare tumor cases.
• Thin Films Electronics technology platform for semiconductor thin film deposition and materials used in chip manufacturing. Supplied under the EMD Electronics brand to semiconductor fabs.
• Optronics Electronics technology combining optics and electronics for displays, sensors, and photonic applications. Sold to display manufacturers and photonics system integrators.
• Formulations Electronics formulations technology for semiconductor materials and chemical processes. Supplied to semiconductor manufacturers for chip fabrication.
• Metrology and Inspection Electronics technology for measurement, quality control, and inspection in semiconductor manufacturing. Used by fabs to validate process performance.
• Delivery Systems and Services (DS&S) Electronics delivery systems and services for gas and chemical delivery in manufacturing processes. Installed at semiconductor fabrication facilities.
• Specialty Gases Electronics specialty gases used in semiconductor fabrication and thin film deposition processes. Sold to semiconductor manufacturers globally.
• Intermolecular® Custom innovation solutions for semiconductor manufacturing through Intermolecular's proprietary technology platform. Serves semiconductor manufacturers seeking co-developed materials and process innovations.

Named customers4 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Bio-TechnecoreStrategic or Co-development Partner · 25 June 2026Merck KGaA, Darmstadt, Germany agreed to acquire Bio-Techne for US$73 per share in cash, representing an enterprise value of US$11.3 billion (EUR 9.9 billion). This acquisition aims to strengthen the company's leadership position in fast-growing Life Sciences markets.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Agilent Technologies: Analytical laboratory instrument and consumables manufacturer serving pharmaceutical, biotech, and chemical-analysis customers. Overlaps with Merck KGaA's Discovery Solutions and Advanced Solutions portfolios in chromatography, mass spectrometry, and lab analytics.
• Sartorius AG: German-headquartered bioprocess solutions specialist (upstream/downstream single-use equipment and consumables). Direct competitor in the same biomanufacturing value chain served by Merck KGaA's Process Solutions business unit.
• Thermo Fisher Scientific: The largest pure-play life-science tools and services company globally. Directly comparable in biopharma process solutions, reagents, analytical instruments, and CDMO services — overlapping with Merck KGaA's MilliporeSigma franchise across nearly every product category.
• Waters Corporation: Specialist in liquid chromatography, mass spectrometry, and laboratory informatics used in pharmaceutical and academic analytical workflows. Direct peer to Merck KGaA's analytical-instrument capabilities in the Life Science portfolio.
• Danaher Corporation: Diversified life-science and diagnostics conglomerate with Cytiva (bioprocessing), Beckman Coulter (analytical), and Leica (microscopy). Direct competitor in bioprocess solutions and lab analytical instruments, with similar business-model and customer-overlap dynamics to MilliporeSigma.
• Lonza Group: Swiss CDMO and bioprocessing leader offering both mammalian and microbial manufacturing services plus cell and gene therapy capabilities. Comparable to Merck KGaA's Life Science services-and-process-solutions portfolio and an indirect competitor in mRNA manufacturing services.
• Bio-Rad Laboratories: Life-science research and clinical diagnostics company with strong positions in protein purification, PCR, and cell biology. Comparable to Merck's Discovery Solutions and to Bio-Techne's portfolio that Merck KGaA is acquiring.
• Eurofins Scientific: Contract laboratory testing and analytical services provider for pharmaceutical, food, environmental, and clinical customers. Adjacent peer in commercial physical and biological research services, overlapping with portions of Merck KGaA's Life Science services catalog.

Emerging players

• WuXi AppTec: Asia-headquartered contract research, development, and manufacturing organization serving global biopharma. Comparable to Merck KGaA's process-solutions and CDMO-related services, particularly relevant given the India biotech focus of the anchor's emerging-biotech initiative.

Broad incumbents

• Roche Holding: Swiss pharmaceutical and diagnostics major with overlapping therapeutic areas (oncology, neurology, immunology) and diagnostics reagents. Comparable to Merck KGaA's EMD Serono Healthcare business in therapeutic-area alignment and global specialty-pharma positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/merckindia
• Facebookfacebook.com/emdgroup
• LinkedInlinkedin.com/company/merck-india
• Instagraminstagram.com/_emdgroup_/?hl=en

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotechnology Industry in India